New York Biotechnology Association
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 987,113 | 1,075,146 | −88,033 | -1.9 | 34% |
| 2013 | 791,933 | 868,979 | −77,046 | -3.4 | 39% |
| 2014 | 827,113 | 793,824 | 33,289 | -3.2 | 46% |
| 2015 | 937,810 | 999,284 | −61,474 | -3.3 | 34% |
| 2016 | 905,087 | 859,717 | 45,370 | -3.2 | 41% |
| 2017 | 1,267,324 | 1,044,489 | 222,835 | -0.3 | 39% |
| 2018 | 389,887 | 234,502 | 155,385 | 3.9 | 58% |
| 2019 | 1,224,465 | 891,621 | 332,844 | 5.6 | 49% |
| 2020 | 862,407 | 818,995 | 43,412 | 6.8 | 63% |
| 2021 | 910,681 | 777,498 | 133,183 | 9.2 | 71% |
| 2022 | 1,043,331 | 920,485 | 122,846 | 9.3 | 62% |
| 2023 | 1,372,461 | 1,104,989 | 267,472 | 10.7 | 55% |
In its most recent public year (2023), this organization brought in $267,472 more than it spent. Its reserves stood at about 10.7 months of spending, up from -1.9 in 2012. Staff pay was 55% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
New York Biotechnology Association's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works